Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gathering information about how often methemoglobinemia occurs in young patients
receiving dapsone for hematologic cancer or aplastic anemia may help doctors learn more about
the disease and plan the best treatment.
PURPOSE: This research study is looking at methemoglobinemia in young patients with
hematologic cancer or aplastic anemia treated with dapsone.
Details
Lead Sponsor:
Vanderbilt University Vanderbilt-Ingram Cancer Center